There are a number of theories on the uses of stem cells with both positive and negative traits being explored by a wide variety of clinics nationwide. While some proponents of the therapy spout it as a miracle heal-all or panacea, others such as with Shubert Regenerative Care are more realistic and know that they cannot cure every malady in the body. In fact, it is important to note that the initial diagnostic that we perform in our clinic focuses on the possible use of both PRP therapy and stem cell injections as sometimes one is preferential to the other for the best results. What then are some of the cases that have occurred in recent years that showcase the negatives and the positives of this new and revolutionary trend? Let’s find out.
While the number of individuals with liver disease continues to rise, there are few options since liver transplantation is problematic due to a lack of availability of donors and risks associated with the procedure. “Cell therapy using human fetal liver-derived stem cells can provide great potential to conservatively manage end-stage liver diseases. Therefore, the present investigation aimed to study and prove the safety and efficacy of human fetal liver-derived stem cell transplantation in patients with end-stage liver cirrhosis” (Khan et. Al, 2010). This provides hope for people who could benefit from this kind of treatment, but it also does not mean that it will be possible for everyone to attain. Stem cells and PRP therapies each work much better in soft matter tissues in the body such as in muscles and organs but there are still risks involved in the therapy being used within such a delicate part of the body. Since the liver is the only naturally repairing and self-regenerating organ in humans, it holds greater promise than therapy in other areas. As a result, this is a treatment that might be very useful soon while others are not as helpful.
Joint damage and regeneration is a major topic of interest in regenerative medicine because of the fact that it these therapies have been shown to lead to positive changes in the body. In particular, “cartilage cells – can be encapsulated in these hydrogels and will form cartilage-like tissue. The cells thrive because hydrogels contain plenty of water, which is needed to carry nutrients to these cells and move waste products away from them. The hydrogels also have enough space to allow the new tissue to form” (Sneiderman, 2018). With the ability to repair damage to the knees and other joints, it limits the need for full joint replacement which can be more harmful than helpful on the body. The result is that joint repair is a viable future for stem cell research although it too is still in the earlier stages of development.
Dangerous alternative treatments
One of the biggest issues with the promotion of stem cell use and their application is the fact that some clinics have promised impossible gains and changes in the body by playing on the idea that it is a cure-all that can fix even the deadliest of problems. In particular, blindness and the treatment of MS or cancer have been touted with less than favorable results. While the application of stem cell therapy and their derivatives hold the possibility of increasing the likelihood of developing treatments, a single injection is not likely to fix these debilitating diseases. It is important to remember that if something sounds too good to be true, it might be and you should do research on the subject. This gives you options and lets you know what treatments are more viable than others.
In the end, the future of the stem cell sector of healthcare shows great promise. Even with some ne’er do wells promoting snake oils style treatments, a little research can go a long way for any patient across the globe. By understanding the process of stem cell therapy, it is possible to see its benefits to the individual and the group. It has a bright future ahead of it and should be regarded as a great innovation which has just not been quite perfected yet but not as something to avoid.
Khan, A., Shaik, M., Parveen, N., Rajendraprasad, A., Aleem, M., Habeeb, M., Srinivas, G., Raj, T., Tiwari, S., Kumaresan, K., Venkateswarlu, J., Pande, G., Habibullah, C. (2010). Human fetal liver-derived stem cell transplantation as supportive modality in the management of end-stage decompensated liver cirrhosis. Cell Transplant. 19(4).
Sneiderman, P. (2018). Joint Repair. John Hopkins Medicine.